A 33 percent stock premium on the buyout of Kensey Nash, an Exton manufacturer of medical devices, that can be absorbed in the body just…

From DSM’s perspective, the acquisition of biomaterial components manufacturer Kensey Nash of Exton in 2012 was an important step in realizing the Netherland-based…